company background image
RNXT

RenovoRx NasdaqCM:RNXT Stock Report

Last Price

US$1.82

Market Cap

US$16.5m

7D

-2.4%

1Y

-74.4%

Updated

29 Nov, 2022

Data

Company Financials +
RNXT fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

RNXT Stock Overview

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors.

RenovoRx, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for RenovoRx
Historical stock prices
Current Share PriceUS$1.82
52 Week HighUS$10.20
52 Week LowUS$1.50
Beta0
1 Month Change3.13%
3 Month Change-13.57%
1 Year Change-74.36%
3 Year Changen/a
5 Year Changen/a
Change since IPO-75.00%

Recent News & Updates

RenovoRx reports Q2 results

Aug 15

Is RenovoRx (NASDAQ:RNXT) In A Good Position To Deliver On Growth Plans?

Aug 04
Is RenovoRx (NASDAQ:RNXT) In A Good Position To Deliver On Growth Plans?

RenovoRx names new finance CFO

Jul 19

Recent updates

Is RenovoRx (NASDAQ:RNXT) In A Good Position To Deliver On Growth Plans?

Aug 04
Is RenovoRx (NASDAQ:RNXT) In A Good Position To Deliver On Growth Plans?

RenovoRx (NASDAQ:RNXT) Is In A Good Position To Deliver On Growth Plans

Mar 16
RenovoRx (NASDAQ:RNXT) Is In A Good Position To Deliver On Growth Plans

We Think RenovoRx (NASDAQ:RNXT) Can Afford To Drive Business Growth

Nov 30
We Think RenovoRx (NASDAQ:RNXT) Can Afford To Drive Business Growth

Shareholder Returns

RNXTUS BiotechsUS Market
7D-2.4%-1.0%-0.9%
1Y-74.4%-15.2%-18.9%

Return vs Industry: RNXT underperformed the US Biotechs industry which returned -16.1% over the past year.

Return vs Market: RNXT underperformed the US Market which returned -20.5% over the past year.

Price Volatility

Is RNXT's price volatile compared to industry and market?
RNXT volatility
RNXT Average Weekly Movement12.4%
Biotechs Industry Average Movement11.1%
Market Average Movement7.4%
10% most volatile stocks in US Market15.5%
10% least volatile stocks in US Market3.3%

Stable Share Price: RNXT is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.

Volatility Over Time: RNXT's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
200910Shaun Bagaihttps://renovorx.com

RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.

RenovoRx, Inc. Fundamentals Summary

How do RenovoRx's earnings and revenue compare to its market cap?
RNXT fundamental statistics
Market CapUS$16.51m
Earnings (TTM)-US$10.09m
Revenue (TTM)n/a

0.0x

P/S Ratio

-1.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
RNXT income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$10.09m
Earnings-US$10.09m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.11
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did RNXT perform over the long term?

See historical performance and comparison